Illinois College of Optometry Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2015
NCT02472223
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Illinois College of Optometry

Active Ingredients

Drugs in Phase 1 Trials (1)

dexamethasone (1 trial)

Drugs in Other Trials (2)

metilcelulosa (1 trial)

povidone-iodine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Conjunctivitis (Phase 1)

Conjunctivitis, Allergic (Phase 1)

Keratoconus (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 3